PDB Short entry for 1TFX HEADER COMPLEX (SERINE PROTEASE/INHIBITOR) 21-JAN-97 1TFX TITLE COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR TITLE 2 WITH PORCINE TRYPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPSIN; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.21.4; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: TISSUE FACTOR PATHWAY INHIBITOR; COMPND 8 CHAIN: C, D; COMPND 9 FRAGMENT: FACTOR XA-BINDING DOMAIN, DOMAIN II; COMPND 10 SYNONYM: TFPI, EPI, LACI; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 ORGAN: BLOOD; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: JE5505; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PFLAG; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 ORGAN: BLOOD; SOURCE 15 TISSUE: BLOOD; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: JE5505; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PFLAG KEYWDS COMPLEX (SERINE PROTEASE-INHIBITOR), HYDROLASE, INHIBITOR, BLOOD KEYWDS 2 COAGULATION, COMPLEX (SERINE PROTEASE-INHIBITOR) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.T.STUBBS,R.HUBER REVDAT 4 09-AUG-23 1TFX 1 REMARK LINK REVDAT 3 24-FEB-09 1TFX 1 VERSN REVDAT 2 01-APR-03 1TFX 1 JRNL REVDAT 1 21-JAN-98 1TFX 0 JRNL AUTH M.J.BURGERING,L.P.ORBONS,A.VAN DER DOELEN,J.MULDERS, JRNL AUTH 2 H.J.THEUNISSEN,P.D.GROOTENHUIS,W.BODE,R.HUBER,M.T.STUBBS JRNL TITL THE SECOND KUNITZ DOMAIN OF HUMAN TISSUE FACTOR PATHWAY JRNL TITL 2 INHIBITOR: CLONING, STRUCTURE DETERMINATION AND INTERACTION JRNL TITL 3 WITH FACTOR XA. JRNL REF J.MOL.BIOL. V. 269 395 1997 JRNL REFN ISSN 0022-2836 JRNL PMID 9199408 JRNL DOI 10.1006/JMBI.1997.1029 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.T.STUBBS,R.MORENWEISER,J.STURZEBECHER,M.BAUER,W.BODE, REMARK 1 AUTH 2 R.HUBER,G.P.PIECHOTTKA,G.MATSCHINER,C.P.SOMMERHOFF,H.FRITZ, REMARK 1 AUTH 3 E.A.AUERSWALD REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT LEECH-DERIVED REMARK 1 TITL 2 TRYPTASE INHIBITOR IN COMPLEX WITH TRYPSIN. IMPLICATIONS FOR REMARK 1 TITL 3 THE STRUCTURE OF HUMAN MAST CELL TRYPTASE AND ITS INHIBITION REMARK 1 REF J.BIOL.CHEM. V. 272 19931 1997 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 2 REMARK 1 AUTH H.BRANDSTETTER,A.KUHNE,W.BODE,R.HUBER,W.VON DER SAAL, REMARK 1 AUTH 2 K.WIRTHENSOHN,R.A.ENGH REMARK 1 TITL X-RAY STRUCTURE OF ACTIVE SITE-INHIBITED CLOTTING FACTOR XA. REMARK 1 TITL 2 IMPLICATIONS FOR DRUG DESIGN AND SUBSTRATE RECOGNITION REMARK 1 REF J.BIOL.CHEM. V. 271 29988 1996 REMARK 1 REFN ISSN 0021-9258 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.T.STUBBS II REMARK 1 TITL STRUCTURAL ASPECTS OF FACTOR XA INHIBITION REMARK 1 REF CURR.PHARM.DES. V. 2 543 1996 REMARK 1 REFN ISSN 1381-6128 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.VAN DE LOCHT,M.T.STUBBS,W.BODE,T.FRIEDRICH, REMARK 1 AUTH 2 C.BOLLSCHWEILER,W.HOFFKEN,R.HUBER REMARK 1 TITL THE ORNITHODORIN-THROMBIN CRYSTAL STRUCTURE, A KEY TO THE REMARK 1 TITL 2 TAP ENIGMA? REMARK 1 REF EMBO J. V. 15 6011 1996 REMARK 1 REFN ISSN 0261-4189 REMARK 1 REFERENCE 5 REMARK 1 AUTH M.T.STUBBS,R.HUBER,W.BODE REMARK 1 TITL CRYSTAL STRUCTURES OF FACTOR XA SPECIFIC INHIBITORS IN REMARK 1 TITL 2 COMPLEX WITH TRYPSIN: STRUCTURAL GROUNDS FOR INHIBITION OF REMARK 1 TITL 3 FACTOR XA AND SELECTIVITY AGAINST THROMBIN REMARK 1 REF FEBS LETT. V. 375 103 1995 REMARK 1 REFN ISSN 0014-5793 REMARK 1 REFERENCE 6 REMARK 1 AUTH K.PADMANABHAN,K.P.PADMANABHAN,A.TULINSKY,C.H.PARK,W.BODE, REMARK 1 AUTH 2 R.HUBER,D.T.BLANKENSHIP,A.D.CARDIN,W.KISIEL REMARK 1 TITL STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 A RESOLUTION REMARK 1 REF J.MOL.BIOL. V. 232 947 1993 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0010 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.5 REMARK 3 NUMBER OF REFLECTIONS : 13757 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.64 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 558 REMARK 3 BIN R VALUE (WORKING SET) : 0.2120 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4238 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 143 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.320 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TFX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176662. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JAN-95 REMARK 200 TEMPERATURE (KELVIN) : 287 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17364 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : 0.10200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : 0.30000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: PORCINE TRYPSIN MODEL FROM LDTI TRYPSIN (PDB ENTRY REMARK 200 1LDT) REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.95000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.85000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 68.85000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.95000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12040 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THIS STRUCTURE IS PART OF A MULTIDISCIPLINARY STUDY INTO REMARK 400 THE STRUCTURE AND FUNCTION OF THE SECOND DOMAIN OF TISSUE REMARK 400 FACTOR PATHWAY INHIBITOR, WHICH IS RESPONSIBLE FOR REMARK 400 SWITCHING OFF THE EARLY STAGES OF BLOOD COAGULATION. REMARK 400 COORDINATES FOR THE NMR SOLUTION STRUCTURE HAVE ALSO BEEN REMARK 400 DEPOSITED AS PDB ENTRY 1ADZ. REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASP C 57 REMARK 475 GLY C 58 REMARK 475 ASP D 57 REMARK 475 GLY D 58 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 49 -12.54 -46.20 REMARK 500 HIS A 71 -63.64 -150.49 REMARK 500 ASN A 115 124.02 107.57 REMARK 500 SER A 116 -66.36 65.89 REMARK 500 SER A 147 -62.20 -109.13 REMARK 500 ASP A 189 175.74 177.53 REMARK 500 SER A 195 142.36 -39.98 REMARK 500 SER A 214 -74.61 -114.69 REMARK 500 ALA A 221 19.73 56.77 REMARK 500 ALA A 243 4.51 -66.61 REMARK 500 SER B 37 22.68 -149.98 REMARK 500 HIS B 71 -58.15 -154.34 REMARK 500 ASN B 115 134.20 98.20 REMARK 500 SER B 116 -73.89 79.78 REMARK 500 SER B 147 -72.97 -107.36 REMARK 500 ASP B 189 170.85 177.58 REMARK 500 SER B 214 -73.42 -132.02 REMARK 500 ARG C 15 38.61 -95.83 REMARK 500 TYR C 17 71.13 -117.03 REMARK 500 ASN C 44 106.30 -160.60 REMARK 500 GLU C 56 -70.94 -79.73 REMARK 500 ASP C 57 58.92 158.84 REMARK 500 ARG D 15 44.60 -102.64 REMARK 500 ASN D 25 23.13 -78.50 REMARK 500 GLU D 56 -75.58 -99.41 REMARK 500 ASP D 57 144.38 178.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1007 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 70 OE1 REMARK 620 2 ASN A 72 O 84.1 REMARK 620 3 VAL A 75 O 138.3 94.3 REMARK 620 4 GLU A 77 OE1 105.0 101.2 116.0 REMARK 620 5 GLU A 80 OE2 87.3 165.4 84.4 92.4 REMARK 620 6 HOH A2053 O 74.2 92.3 64.3 166.4 74.0 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B4007 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU B 70 OE1 REMARK 620 2 ASN B 72 O 81.2 REMARK 620 3 VAL B 75 O 146.3 93.2 REMARK 620 4 GLU B 77 OE1 102.9 90.7 110.5 REMARK 620 5 GLU B 80 OE2 91.9 166.6 98.9 79.6 REMARK 620 6 HOH B5053 O 73.9 112.4 77.8 155.4 76.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 4007 DBREF 1TFX A 16 245 UNP P00761 TRYP_PIG 9 231 DBREF 1TFX B 16 245 UNP P00761 TRYP_PIG 9 231 DBREF 1TFX C 1 58 UNP P10646 TFPI1_HUMAN 121 178 DBREF 1TFX D 1 58 UNP P10646 TFPI1_HUMAN 121 178 SEQRES 1 A 223 ILE VAL GLY GLY TYR THR CYS ALA ALA ASN SER ILE PRO SEQRES 2 A 223 TYR GLN VAL SER LEU ASN SER GLY SER HIS PHE CYS GLY SEQRES 3 A 223 GLY SER LEU ILE ASN SER GLN TRP VAL VAL SER ALA ALA SEQRES 4 A 223 HIS CYS TYR LYS SER ARG ILE GLN VAL ARG LEU GLY GLU SEQRES 5 A 223 HIS ASN ILE ASP VAL LEU GLU GLY ASN GLU GLN PHE ILE SEQRES 6 A 223 ASN ALA ALA LYS ILE ILE THR HIS PRO ASN PHE ASN GLY SEQRES 7 A 223 ASN THR LEU ASP ASN ASP ILE MET LEU ILE LYS LEU SER SEQRES 8 A 223 SER PRO ALA THR LEU ASN SER ARG VAL ALA THR VAL SER SEQRES 9 A 223 LEU PRO ARG SER CYS ALA ALA ALA GLY THR GLU CYS LEU SEQRES 10 A 223 ILE SER GLY TRP GLY ASN THR LYS SER SER GLY SER SER SEQRES 11 A 223 TYR PRO SER LEU LEU GLN CYS LEU LYS ALA PRO VAL LEU SEQRES 12 A 223 SER ASP SER SER CYS LYS SER SER TYR PRO GLY GLN ILE SEQRES 13 A 223 THR GLY ASN MET ILE CYS VAL GLY PHE LEU GLU GLY GLY SEQRES 14 A 223 LYS ASP SER CYS GLN GLY ASP SER GLY GLY PRO VAL VAL SEQRES 15 A 223 CYS ASN GLY GLN LEU GLN GLY ILE VAL SER TRP GLY TYR SEQRES 16 A 223 GLY CYS ALA GLN LYS ASN LYS PRO GLY VAL TYR THR LYS SEQRES 17 A 223 VAL CYS ASN TYR VAL ASN TRP ILE GLN GLN THR ILE ALA SEQRES 18 A 223 ALA ASN SEQRES 1 B 223 ILE VAL GLY GLY TYR THR CYS ALA ALA ASN SER ILE PRO SEQRES 2 B 223 TYR GLN VAL SER LEU ASN SER GLY SER HIS PHE CYS GLY SEQRES 3 B 223 GLY SER LEU ILE ASN SER GLN TRP VAL VAL SER ALA ALA SEQRES 4 B 223 HIS CYS TYR LYS SER ARG ILE GLN VAL ARG LEU GLY GLU SEQRES 5 B 223 HIS ASN ILE ASP VAL LEU GLU GLY ASN GLU GLN PHE ILE SEQRES 6 B 223 ASN ALA ALA LYS ILE ILE THR HIS PRO ASN PHE ASN GLY SEQRES 7 B 223 ASN THR LEU ASP ASN ASP ILE MET LEU ILE LYS LEU SER SEQRES 8 B 223 SER PRO ALA THR LEU ASN SER ARG VAL ALA THR VAL SER SEQRES 9 B 223 LEU PRO ARG SER CYS ALA ALA ALA GLY THR GLU CYS LEU SEQRES 10 B 223 ILE SER GLY TRP GLY ASN THR LYS SER SER GLY SER SER SEQRES 11 B 223 TYR PRO SER LEU LEU GLN CYS LEU LYS ALA PRO VAL LEU SEQRES 12 B 223 SER ASP SER SER CYS LYS SER SER TYR PRO GLY GLN ILE SEQRES 13 B 223 THR GLY ASN MET ILE CYS VAL GLY PHE LEU GLU GLY GLY SEQRES 14 B 223 LYS ASP SER CYS GLN GLY ASP SER GLY GLY PRO VAL VAL SEQRES 15 B 223 CYS ASN GLY GLN LEU GLN GLY ILE VAL SER TRP GLY TYR SEQRES 16 B 223 GLY CYS ALA GLN LYS ASN LYS PRO GLY VAL TYR THR LYS SEQRES 17 B 223 VAL CYS ASN TYR VAL ASN TRP ILE GLN GLN THR ILE ALA SEQRES 18 B 223 ALA ASN SEQRES 1 C 58 LYS PRO ASP PHE CYS PHE LEU GLU GLU ASP PRO GLY ILE SEQRES 2 C 58 CYS ARG GLY TYR ILE THR ARG TYR PHE TYR ASN ASN GLN SEQRES 3 C 58 THR LYS GLN CYS GLU ARG PHE LYS TYR GLY GLY CYS LEU SEQRES 4 C 58 GLY ASN MET ASN ASN PHE GLU THR LEU GLU GLU CYS LYS SEQRES 5 C 58 ASN ILE CYS GLU ASP GLY SEQRES 1 D 58 LYS PRO ASP PHE CYS PHE LEU GLU GLU ASP PRO GLY ILE SEQRES 2 D 58 CYS ARG GLY TYR ILE THR ARG TYR PHE TYR ASN ASN GLN SEQRES 3 D 58 THR LYS GLN CYS GLU ARG PHE LYS TYR GLY GLY CYS LEU SEQRES 4 D 58 GLY ASN MET ASN ASN PHE GLU THR LEU GLU GLU CYS LYS SEQRES 5 D 58 ASN ILE CYS GLU ASP GLY HET CA A1007 1 HET CA B4007 1 HETNAM CA CALCIUM ION FORMUL 5 CA 2(CA 2+) FORMUL 7 HOH *143(H2 O) HELIX 1 1 ALA A 56 CYS A 58 5 3 HELIX 2 2 ASP A 165 SER A 171 1 7 HELIX 3 3 VAL A 231 ALA A 244 5 14 HELIX 4 4 ALA B 56 CYS B 58 5 3 HELIX 5 5 ASP B 165 SER B 171 1 7 HELIX 6 6 VAL B 231 ALA B 244 5 14 HELIX 7 7 ASP C 3 PHE C 6 5 4 HELIX 8 8 LEU C 48 ILE C 54 1 7 HELIX 9 9 ASP D 3 PHE D 6 5 4 HELIX 10 10 LEU D 48 CYS D 55 1 8 SHEET 1 A 7 GLN A 81 ASN A 84 0 SHEET 2 A 7 GLN A 64 LEU A 67 -1 N LEU A 67 O GLN A 81 SHEET 3 A 7 GLN A 30 ASN A 34 -1 N ASN A 34 O GLN A 64 SHEET 4 A 7 HIS A 40 ASN A 48 -1 N GLY A 44 O VAL A 31 SHEET 5 A 7 TRP A 51 SER A 54 -1 N VAL A 53 O SER A 45 SHEET 6 A 7 MET A 104 LEU A 108 -1 N ILE A 106 O VAL A 52 SHEET 7 A 7 ALA A 85 THR A 90 -1 N ILE A 89 O LEU A 105 SHEET 1 B 6 GLN A 156 PRO A 161 0 SHEET 2 B 6 GLU A 135 GLY A 140 -1 N GLY A 140 O GLN A 156 SHEET 3 B 6 PRO A 198 CYS A 201 -1 N VAL A 200 O LEU A 137 SHEET 4 B 6 GLN A 204 TRP A 215 -1 N GLY A 211 O VAL A 199 SHEET 5 B 6 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212 SHEET 6 B 6 MET A 180 VAL A 183 -1 N VAL A 183 O GLY A 226 SHEET 1 C 7 GLN B 81 ASN B 84 0 SHEET 2 C 7 GLN B 64 LEU B 67 -1 N LEU B 67 O GLN B 81 SHEET 3 C 7 GLN B 30 ASN B 34 -1 N ASN B 34 O GLN B 64 SHEET 4 C 7 HIS B 40 ASN B 48 -1 N GLY B 44 O VAL B 31 SHEET 5 C 7 TRP B 51 SER B 54 -1 N VAL B 53 O SER B 45 SHEET 6 C 7 MET B 104 LEU B 108 -1 N ILE B 106 O VAL B 52 SHEET 7 C 7 ALA B 85 THR B 90 -1 N ILE B 89 O LEU B 105 SHEET 1 D 2 GLU B 135 GLY B 140 0 SHEET 2 D 2 GLN B 156 PRO B 161 -1 N ALA B 160 O CYS B 136 SHEET 1 E 4 MET B 180 VAL B 183 0 SHEET 2 E 4 GLY B 226 LYS B 230 -1 N TYR B 228 O ILE B 181 SHEET 3 E 4 GLN B 204 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 4 E 4 PRO B 198 CYS B 201 -1 N CYS B 201 O GLN B 204 SHEET 1 F 2 ILE C 18 ASN C 24 0 SHEET 2 F 2 GLN C 29 TYR C 35 -1 N TYR C 35 O ILE C 18 SHEET 1 G 2 ILE D 18 ASN D 24 0 SHEET 2 G 2 GLN D 29 TYR D 35 -1 N TYR D 35 O ILE D 18 SSBOND 1 CYS A 22 CYS A 157 1555 1555 2.02 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 128 CYS A 232 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.02 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 7 CYS B 22 CYS B 157 1555 1555 2.42 SSBOND 8 CYS B 128 CYS B 232 1555 1555 2.40 SSBOND 9 CYS B 136 CYS B 201 1555 1555 2.37 SSBOND 10 CYS B 168 CYS B 182 1555 1555 2.47 SSBOND 11 CYS B 191 CYS B 220 1555 1555 2.39 SSBOND 12 CYS C 5 CYS C 55 1555 1555 2.03 SSBOND 13 CYS C 14 CYS C 38 1555 1555 2.04 SSBOND 14 CYS C 30 CYS C 51 1555 1555 2.03 SSBOND 15 CYS D 14 CYS D 38 1555 1555 2.41 LINK OE1 GLU A 70 CA CA A1007 1555 1555 2.98 LINK O ASN A 72 CA CA A1007 1555 1555 2.20 LINK O VAL A 75 CA CA A1007 1555 1555 2.10 LINK OE1 GLU A 77 CA CA A1007 1555 1555 2.40 LINK OE2 GLU A 80 CA CA A1007 1555 1555 2.46 LINK CA CA A1007 O HOH A2053 1555 1555 3.25 LINK OE1 GLU B 70 CA CA B4007 1555 1555 2.10 LINK O ASN B 72 CA CA B4007 1555 1555 2.19 LINK O VAL B 75 CA CA B4007 1555 1555 2.12 LINK OE1 GLU B 77 CA CA B4007 1555 1555 2.87 LINK OE2 GLU B 80 CA CA B4007 1555 1555 2.11 LINK CA CA B4007 O HOH B5053 1555 1555 3.04 SITE 1 AC1 5 GLU A 70 ASN A 72 VAL A 75 GLU A 77 SITE 2 AC1 5 GLU A 80 SITE 1 AC2 6 GLU B 70 ASN B 72 VAL B 75 GLU B 77 SITE 2 AC2 6 GLU B 80 HOH B5053 CRYST1 41.900 96.200 137.700 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023866 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010395 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007262 0.00000 MTRIX1 1 0.999900 -0.011400 0.000800 6.31810 1 MTRIX2 1 0.011300 0.975500 -0.219900 -39.90060 1 MTRIX3 1 0.001700 0.219900 0.975500 -7.80590 1